| |
Mentat® , an indigenous, Ayurvedic preparation containing Bacopa monniera , Centella asiatica , Withania somnifera , Evolvulus alsinoides and Nardostachys jatamansi , was tested for its efficacy in patients suffering from functional impairment following stroke. Twenty-four patients participated in the study. Thirteen patients received Mentat® , and eleven patients received placebo for a 12-week period. The Mentat® patients had better EMG (electromyographic) responses compared to the placebo group after 12 weeks. |
|
